Hepatosplenic T cell lymphoma laboratory tests

Hepatosplenic T cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hepatosplenic T cell lymphoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatosplenic T cell lymphoma laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatosplenic T cell lymphoma laboratory tests
CDC on Hepatosplenic T cell lymphoma laboratory tests
Hepatosplenic T cell lymphoma laboratory tests in the news
Blogs on Hepatosplenic T cell lymphoma laboratory tests
Directions to Hospitals Treating Hepatosplenic T cell lymphoma
Risk calculators and risk factors for Hepatosplenic T cell lymphoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

The constellation of thrombocytopenia, anemia, and leukocytosis is common in patients with hepatosplenic T-cell lymphoma. The discovery of neoplastic cells in peripheral blood is often a finding late in the clinical course.